$BSPK
Bespoke Extracts, Inc.

2023 Q2 Form 10-Q Financial Statement

#000121390023080228 Filed on September 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $188.2K $350.00
YoY Change 53684.86% -96.54%
Cost Of Revenue $117.2K $46.67K
YoY Change 151.16% 696.25%
Gross Profit $71.04K -$46.32K
YoY Change -253.35% -651.78%
Gross Profit Margin 37.74% -13234.86%
Selling, General & Admin $457.4K $894.9K
YoY Change -48.89% 469.77%
% of Gross Profit 643.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $538.5K $965.9K
YoY Change -44.25% 278.29%
Operating Profit -$467.5K -$1.012M
YoY Change -53.81% 309.91%
Interest Expense -$250.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.587K $250.00
YoY Change 934.8%
Pretax Income -$464.9K -$1.012M
YoY Change -54.06% 309.81%
Income Tax
% Of Pretax Income
Net Earnings -$464.9K -$1.012M
YoY Change -54.06% 309.81%
Net Earnings / Revenue -246.97% -289137.71%
Basic Earnings Per Share -$0.05 $0.00
Diluted Earnings Per Share -$0.05 $0.00
COMMON SHARES
Basic Shares Outstanding 10.17M shares 351.5M shares
Diluted Shares Outstanding 10.17M shares 351.5M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $24.57K
YoY Change -100.0% -70.45%
Cash & Equivalents $1.947K $24.57K
Short-Term Investments
Other Short-Term Assets $50.00K $25.34K
YoY Change 97.32% -72.46%
Inventory $42.36K $0.00
Prepaid Expenses $14.45K $13.34K
Receivables $42.31K $3.478K
Other Receivables $0.00 $0.00
Total Short-Term Assets $137.9K $73.82K
YoY Change 86.74% -71.26%
LONG-TERM ASSETS
Property, Plant & Equipment $45.38K $9.947K
YoY Change 356.23% 261.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00K $12.72K
YoY Change -21.38%
Total Long-Term Assets $310.4K $330.8K
YoY Change -6.16% 811.07%
TOTAL ASSETS
Total Short-Term Assets $137.9K $73.82K
Total Long-Term Assets $310.4K $330.8K
Total Assets $448.3K $404.6K
YoY Change 10.79% 38.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $650.0K $159.0K
YoY Change 308.75% 155.91%
Accrued Expenses $60.00K $62.80K
YoY Change -4.46%
Deferred Revenue
YoY Change
Short-Term Debt $40.00K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $758.1K $296.8K
YoY Change 155.4% -47.25%
LONG-TERM LIABILITIES
Long-Term Debt $850.0K $0.00
YoY Change
Other Long-Term Liabilities $180.0K $247.9K
YoY Change -27.39%
Total Long-Term Liabilities $1.030M $247.9K
YoY Change 315.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $758.1K $296.8K
Total Long-Term Liabilities $1.030M $247.9K
Total Liabilities $1.791M $544.7K
YoY Change 228.82% -3.19%
SHAREHOLDERS EQUITY
Retained Earnings -$24.79M -$21.75M
YoY Change 13.96%
Common Stock $10.17K $368.1K
YoY Change -97.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.343M -$140.1K
YoY Change
Total Liabilities & Shareholders Equity $448.3K $404.6K
YoY Change 10.79% 38.02%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$464.9K -$1.012M
YoY Change -54.06% 309.81%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$190.0K -$210.7K
YoY Change -9.82% -49.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$6.270K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$6.270K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.0K 147.2K
YoY Change 29.08%
NET CHANGE
Cash From Operating Activities -190.0K -210.7K
Cash From Investing Activities 0.000 -6.270K
Cash From Financing Activities 190.0K 147.2K
Net Change In Cash 0.000 -69.75K
YoY Change -100.0% -83.33%
FREE CASH FLOW
Cash From Operating Activities -$190.0K -$210.7K
Capital Expenditures $0.00 -$6.270K
Free Cash Flow -$190.0K -$204.4K
YoY Change -7.05% -51.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52759
dei Entity Registrant Name
EntityRegistrantName
BESPOKE EXTRACTS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4743354
dei Entity Address Address Line1
EntityAddressAddressLine1
12001 E. 33rd Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit O
dei Entity Address City Or Town
EntityAddressCityOrTown
Aurora
dei Entity Address Country
EntityAddressCountry
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80010
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
633-3738
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10168220 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1947 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24433 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42310 usd
CY2023Q2 bspk Prepaid Stock Awards
PrepaidStockAwards
36785 usd
CY2022Q4 bspk Prepaid Stock Awards
PrepaidStockAwards
80113 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14445 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7186 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
42364 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
137851 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
111732 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45381 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9947 usd
CY2023Q2 bspk License
License
10000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
243054 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
275912 usd
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
2.25
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12000 usd
CY2023Q2 us-gaap Assets
Assets
448286 usd
CY2022Q4 us-gaap Assets
Assets
409591 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
647884 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
295818 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
90000 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9896 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
35954 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
415500 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64330 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64330 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
758064 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
865648 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
849500 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
183577 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
216039 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1791141 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1081687 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10168220 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10168220 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9946067 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9946067 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
10166 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9944 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23436312 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23201758 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24789333 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23883798 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1342855 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-672096 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
448286 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
409591 usd
CY2023Q2 us-gaap Revenues
Revenues
188247 usd
CY2022Q2 us-gaap Revenues
Revenues
346 usd
us-gaap Revenues
Revenues
277263 usd
us-gaap Revenues
Revenues
3407 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
117211 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46668 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
195878 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
47515 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
71036 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-46322 usd
us-gaap Gross Profit
GrossProfit
81385 usd
us-gaap Gross Profit
GrossProfit
-44108 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
457366 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
894917 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
831881 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1792451 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
63172 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
35493 usd
us-gaap Professional Fees
ProfessionalFees
124376 usd
us-gaap Professional Fees
ProfessionalFees
89848 usd
CY2023Q2 bspk Consulting Fees
ConsultingFees
18000 usd
CY2022Q2 bspk Consulting Fees
ConsultingFees
35500 usd
bspk Consulting Fees
ConsultingFees
36000 usd
bspk Consulting Fees
ConsultingFees
58500 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
538538 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
965910 usd
us-gaap Operating Expenses
OperatingExpenses
992257 usd
us-gaap Operating Expenses
OperatingExpenses
1940799 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-467502 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1012232 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-910872 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1984907 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
2587 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
5337 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
-250 usd
us-gaap Interest Expense
InterestExpense
-431 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2587 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
250 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5337 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
431 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-464915 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1011982 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-905535 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1984476 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-464915 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1011982 usd
us-gaap Net Income Loss
NetIncomeLoss
-905535 usd
us-gaap Net Income Loss
NetIncomeLoss
-1984476 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10168220 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7812084 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10164537 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7404386 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1986603 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
708253 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
147200 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1011982 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1830074 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-970284 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
92344 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-464915 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1342855 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1989961 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
4792 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1475347 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
344450 usd
us-gaap Net Income Loss
NetIncomeLoss
-1984476 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1830074 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-672096 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
50000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
184776 usd
us-gaap Net Income Loss
NetIncomeLoss
-905535 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1342855 usd
us-gaap Net Income Loss
NetIncomeLoss
-905535 usd
us-gaap Net Income Loss
NetIncomeLoss
-1984476 usd
bspk Inventory Reserve
InventoryReserve
40393 usd
bspk Inventory Reserve
InventoryReserve
46825 usd
us-gaap Depreciation
Depreciation
4566 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
32858 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
43328 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
31638 usd
us-gaap Share Based Compensation
ShareBasedCompensation
184776 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1435860 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9856 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-158 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7259 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6898 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
82757 usd
bspk Interest Receivable Wonder Leaf
InterestReceivableWonderLeaf
431 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
319612 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
76293 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9896 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-32462 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-29442 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-402440 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-430473 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
12719 usd
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
20000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7202 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39921 usd
bspk Proceeds Of Inventory Earnout
ProceedsOfInventoryEarnout
90000 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
4792 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
469954 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2500 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
344449 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
379954 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
346741 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22486 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-123653 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24433 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148227 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1947 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24574 usd
us-gaap Stock Issued1
StockIssued1
50000 usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
222223 shares
CY2023Q1 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
50000 usd
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.225
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0 usd
us-gaap Gain On Cash Flow Hedge Ineffectiveness
GainOnCashFlowHedgeIneffectiveness
402440 usd
bspk Working Capital Deficit
WorkingCapitalDeficit
620213 usd
CY2023Q2 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
24789333 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. </p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
42364 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
0 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
42364 usd
CY2023Q2 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2022 bspk Total Accounts Receivable
TotalAccountsReceivable
0.10 pure
bspk Number Of Customer
NumberOfCustomer
1 pure
bspk Sales Percentage
SalesPercentage
0.516 pure
CY2022Q2 bspk Total Sales In Percentage
TotalSalesInPercentage
0.10 pure
bspk Total Sales In Percentage
TotalSalesInPercentage
0.10 pure
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Deferred Revenue</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue represents services or products that were paid for but not delivered to the customer as of June 30, 2023.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior gross prepaid stock compensation and additional paid in capital presented in the 10-Q for the period end June 30, 2022 have been reclassified to conform with the financial statements filed in the December 31, 2022 10-K.</p>
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
562.967 shares
CY2023Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
222223 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
50000 usd
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.225
CY2023Q2 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
50000 usd
CY2023Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
222223 shares
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
50000 usd
us-gaap Taxes And Licenses
TaxesAndLicenses
10000 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
40000 usd
CY2022Q3 bspk Operating Profit Sale Percentage
OperatingProfitSalePercentage
0.40 pure
CY2022Q3 bspk Inventory Earn Out
InventoryEarnOut
75000 usd
CY2022Q4 bspk Inventory Earn Out
InventoryEarnOut
90000 usd
CY2022Q1 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
10000 usd
CY2022Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.05 pure
CY2022Q1 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-01-18
CY2022Q1 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
10000 usd
CY2022Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.05 pure
CY2022Q1 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-02-08
CY2022Q4 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
25000 usd
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.05 pure
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-02-08
CY2022 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
931 usd
CY2022 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
45931 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49947 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9947 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4566 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45381 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9947 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
2781 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4566 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
0 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
0 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
469954 usd
CY2023Q2 bspk Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
885454 usd
CY2022Q4 bspk Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
415500 usd
CY2023Q2 us-gaap Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
P5Y
CY2023Q2 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
us-gaap Payments For Rent
PaymentsForRent
6000 usd
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
600000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y5M8D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04 pure
us-gaap Operating Lease Cost
OperatingLeaseCost
38186 usd
us-gaap Lease Cost
LeaseCost
40286 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
675000 usd
CY2022 bspk Shares Issued To Investors
SharesIssuedToInvestors
1530897 shares
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1530897 shares
CY2022 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
344450 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2023-06-30
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
37800 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
75915 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
79380 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
72765 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
265850 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
17953 usd
CY2023Q2 bspk Total Present Value Of Lease Liabilities
TotalPresentValueOfLeaseLiabilities
247907 usd
bspk Rightofuse Assets Classification
RightofuseAssetsClassification
Right of use assets
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
243054 usd
bspk Current Lease Liabilities Classification
CurrentLeaseLiabilitiesClassification
Current operating lease liabilities
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64330 usd
bspk Noncurrent Lease Liabilities Classification
NoncurrentLeaseLiabilitiesClassification
Long-term operating lease liabilities
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
183577 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
247907 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
222223 shares
CY2023Q1 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
50000 usd
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.225
CY2022Q3 bspk Shares Of Common Stock
SharesOfCommonStock
266667 shares
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
155556 shares
CY2022 us-gaap Other Expenses
OtherExpenses
1104928 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
21544 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
43328 usd
us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
38785 usd
CY2022 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
80113 usd
bspk Shares Issued To Investors
SharesIssuedToInvestors
50000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
12500000 shares
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
250000 usd
us-gaap Legal Fees
LegalFees
10000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
2.25
us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
900000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
61621 usd
us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
123343 usd
us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
271188 usd
CY2021Q4 us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
22222 shares
CY2021Q4 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
1.35
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
30000 usd
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
24900 usd
us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
327949 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10164537 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10168220 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7404386 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7812084 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
bspk Advance Amount
AdvanceAmount
469954 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
885454 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
415500 usd
CY2023Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
135000 usd
CY2023Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
111393 usd
CY2021Q3 bspk Principal Amounts
PrincipalAmounts
400000 usd
CY2022Q3 bspk Operating Profit Percentage
OperatingProfitPercentage
0.40 pure
CY2022Q4 us-gaap Progress Payments Netted Against Inventory For Long Term Contracts Or Programs
ProgressPaymentsNettedAgainstInventoryForLongTermContractsOrPrograms
90000 usd
CY2021Q4 bspk Executive Officer Salary
ExecutiveOfficerSalary
8000 usd
CY2021Q4 bspk Stock Issued During Period Shares Others
StockIssuedDuringPeriodSharesOthers
666667 shares
CY2021Q4 us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
0.06
CY2021Q4 bspk Premium Percentage
PremiumPercentage
1.20 pure
CY2023Q2 us-gaap Securities Loaned
SecuritiesLoaned
15000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Interest And Other Income
InterestAndOtherIncome
usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
usd
us-gaap Interest Expense
InterestExpense
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Depreciation
Depreciation
usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
bspk Interest Receivable Wonder Leaf
InterestReceivableWonderLeaf
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
usd
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
bspk Proceeds Of Inventory Earnout
ProceedsOfInventoryEarnout
usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
us-gaap Operating Lease Payments
OperatingLeasePayments
usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
13554 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001409197

Files In Submission

Name View Source Status
bspk-20230630_def.xml Edgar Link unprocessable
bspk-20230630_cal.xml Edgar Link unprocessable
bspk-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bspk-20230630_pre.xml Edgar Link unprocessable
0001213900-23-080228-index-headers.html Edgar Link pending
0001213900-23-080228-index.html Edgar Link pending
0001213900-23-080228.txt Edgar Link pending
0001213900-23-080228-xbrl.zip Edgar Link pending
bspk-20230630.xsd Edgar Link pending
f10q0623ex10-1_bespoke.htm Edgar Link pending
f10q0623ex31-1_bespoke.htm Edgar Link pending
f10q0623ex32-1_bespoke.htm Edgar Link pending
f10q0623_bespoke.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
f10q0623_bespoke_htm.xml Edgar Link completed